• Explore /
  • Poster
  • / A phase II study of S-1, oxaliplatin, and nab-paclitaxel, and itraconazole aimed at conversion surgery for advanced and recurrent gastric cancer.

A phase II study of S-1, oxaliplatin, and nab-paclitaxel, and itraconazole aimed at conversion surgery for advanced and recurrent gastric cancer.

Abstract Poster

Authors

null

Yoshihiko Nakamoto

Meiwa Hospital, Nishinomiya, Japan

Yoshihiko Nakamoto , Hiroshi Tsubamoto , Miyuki Sawazaki , Ayako Kakuno , Takashi Sonoda

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Noncolorectal) Cancer

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Esophageal or Gastric Cancer

Clinical Trial Registration Number

UMIN000021340

Citation

J Clin Oncol 37, 2019 (suppl; abstr 4026)

DOI

10.1200/JCO.2019.37.15_suppl.4026

Abstract #

4026

Poster Bd #

131

Abstract Disclosures

Similar Posters

Poster

2020 Gastrointestinal Cancers Symposium

A phase II trial of low-dose nab-paclitaxel for patients with previously treated or recurrent advanced gastric cancer (OGSG1302).

A phase II trial of low-dose nab-paclitaxel for patients with previously treated or recurrent advanced gastric cancer (OGSG1302).

First Author: Masashi Hirota

First Author: Sarbajit Mukherjee

First Author: Tara Elisabeth Seery

First Author: Rutika Mehta